Floatz logo

Prevenar®

Ataxia Telangiectasia

Sheba Medical CentervaccineDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Ataxia Telangiectasia cohort.

Asset / SponsorPhaseRating
17-beta-estradiol
Johann Wolfgang Goethe University Hospital
Phase 4BB
ARG
Johann Wolfgang Goethe University Hospital
Phase 4BB
ROPIVACAINE
Quince Therapeutics S.p.A.
Phase 3BB
Genotropin
Johann Wolfgang Goethe University Hospital
Phase 4BB
DEXAMETHASONE
Quince Therapeutics S.p.A.
Phase 3B

View all 13 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →